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Astrocytes exhibit a prominent glycolytic activity, but whether such a metabolic profile is influenced by intercellular communication is
unknown. Treatment of primary cultures of mouse cortical astrocytes with the nitric oxide (NO) donor DetaNONOate induced a time-
dependent enhancement in the expression of genes encoding various glycolytic enzymes as well as transporters for glucose and lactate.
Such an effect was shown to be dependent on the hypoxia-inducible factor HIF-1, which is stabilized and translocated to the nucleus to
exert its transcriptional regulation.NOactionwas dependent onboth thePI3K/Akt/mTORandMEKsignaling pathways and required the
activation of COX, but was independent of the soluble guanylate cyclase pathway. Furthermore, as a consequence of NO treatment, an
enhanced lactate production and release by astrocyteswas evidenced, whichwas prevented by downregulatingHIF-1. Several brain cell
types represent possible sources of NO. It was found that endothelial cells, which express the endothelial NO synthase (eNOS) isoform,
constitutively produced the largest amount of NO in culture. When astrocytes were cocultured with primary cultures of brain vascular
endothelial cells, stabilization of HIF-1 and an enhancement in glucose transporter-1, hexokinase-2, and monocarboxylate
transporter-4 expression as well as increased lactate production was found in astrocytes. This effect was inhibited by the NOS inhibitor
L-NAME and was not seen when astrocytes were cocultured with primary cultures of cortical neurons. Our findings suggest that endo-
thelial cell-derivedNOparticipates to themaintenanceof ahigh glycolytic activity in astrocytesmediatedby astrocyticHIF-1 activation.
Introduction
In recent years, the concept that astrocytes, neurons and endo-
thelial cells forming microvessels are organized into structural
neurovascular units became fundamental for the understanding
of cerebral blood flow regulation as well as blood–brain barrier
(BBB) establishment and modulation (Iadecola, 2004). Astro-
cytes have been shown to be involved in the regulation andmain-
tenance of physical, transport as well as metabolic characteristics
of the BBB (Rubin et al., 1991; Hayashi et al., 1997; Haseloff et al.,
2005). On the other hand, as partners in a bidirectional commu-
nication, endothelial cells release factors like the leukemia inhib-
itory factor (LIF) which are crucial for astrocyte differentiation
(Mi et al., 2001). Furthermore, endothelial cells provide brain
cells with glucose via a transcellular transport involving the glu-
cose transporter isoform GLUT1 (Simpson et al., 2007). In this
context, astrocytes have been proposed to provide an important
link between endothelial cells and neurons. Coupling of neuronal
activity with both vascular and metabolic responses are among
the most important proposed functions of astrocytes in these
neurovascular units (Zonta et al., 2003a; Giaume et al., 2010;
Zhou et al., 2010). According to the astrocyte-neuron lactate
shuttle model, astrocytes respond to neuronal activity by con-
verting glucose into lactate that is subsequently taken up by neu-
rons to satisfy their energy needs during activation (Pellerin and
Magistretti, 1994). However until now, no explanation has been
provided for the prominent glycolytic profile exhibited by astro-
cytes under these conditions. Considering the tight interactions
between the different cell types forming neurovascular units, it
could be possible that some intercellular signals determine spe-
cific metabolic characteristics in each cell type.
Nitric oxide (NO) has been identified as an important inter-
cellularmessenger in theCNS and can be produced bymost brain
cells which include astrocytes, neurons and endothelial cells
(Garthwaite and Boulton, 1995). NOwas shown to play a critical
role in numerous brain functions such as the regulation of vas-
cular tone (Akgo¨ren et al., 1996) aswell as long-termpotentiation
(Hopper and Garthwaite, 2006). NOwas also found to modulate
energymetabolism. Thus, NO inhibits oxidativemetabolism and
enhances glycolysis in astrocytes but not in neurons (Almeida et
al., 2001). More recently, it was shown that NO stimulates the
expression of the monocarboxylate transporter MCT4 in astro-
cytes, an effect that was accompanied by a long-lasting enhance-
ment in lactate production and release (Marcillac et al., 2011).
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Such an observation suggests that NOmight coordinate the tran-
scriptional activation of several genes related to glycolysis, al-
though the specific transcription factor involved is unknown.
Moreover, the cellular source of NO that could be responsible for
modulating the metabolic profile of astrocytes has not been de-
termined. Here we provide evidence that NO produced by brain
endothelial cells may be a key factor to maintain elevated aerobic
glycolysis capacity in astrocytes via HIF-1 activation.
Materials andMethods
If not indicated otherwise, chemicals and cell culture media were pur-
chased from Sigma-Aldrich or Invitrogen.
Cell cultures and treatments
The immortalized mouse brain endothelial capillary cell line bEnd.3 was
purchased from ATCC and cultured in DMEM supplemented with 10%
fetal calf serum. Chinese hamster ovarian cells (CHO) were obtained from
ATCC and cultured in HAM’s F12 with 5% FCS. Murine primary cortical
astrocyte-enriched, neuronal cultures or endothelial cells from brain capil-
laries were prepared frommale C57BL/6J mice (The Jackson Laboratory).
Astrocytes. Primary cortical astrocyte-enriched cultures were prepared
from mice at postnatal day 1 as previously described (Sorg and Magis-
tretti, 1992). Following isolation of cortices and removal of themeninges,
dissociated cells were suspended inDMEM supplemented with 10% FCS
and 1% 100  Antibiotic-Antimycotic (v/v). Cells were seeded on 24-
well imaging plates (zell-kontakt) with a gas-permeable bottom to avoid
hypoxia in astrocytes. Experiments were performed after 21 (2) d in
culture at 37°C and 5% CO2. Medium was exchanged every 3–4 d.
Neurons. Primary cortical neuronal cultures were obtained frommice
at embryonic day 18 as described previously (Zerarka et al., 2001). In
brief, cortices were isolated and neurons mechanically dissociated. Pri-
mary neurons were cultured in neurobasal medium supplemented with
1% B27 supplement and 0.25% L-glutamate. 2  105 or 3  105 cells
were seeded per well on poly-L-ornithine-coated 24-well or 12-well
plates, respectively. Experiments were performed after 7 d in culture at
37°C and 5% CO2.
Endothelial cells. Endothelial cells from brain capillaries were isolated
from 12-week-old mice (Song and Pachter, 2003). Briefly, brains were
freed from meninges, homogenized and the cell suspension was centri-
fuged with 18% dextran solution to clear the suspension from myelin.
The cell suspension was digested for 1 h 15 min at 37°C in DMEM
containing 2% FCS, 0.1% collagenase/dispase (0.1 U/ml, 0.8 U/ml, re-
spectively), 0.1% DNaseI, and 0.147 g/ml tosyllysine chloromethyl ke-
tone. Cells were washed with phosphate buffer saline (PBS) and
resuspended in culture medium (DMEM, 20% FCS, 1% Antibiotic-
Antimycotic (v/v), 1% L-glutamine (v/v), 1% endothelial cell growth
supplement (ECGS), 50,000 U heparin) and 8 g/ml puromycin. Me-
diumwas exchanged on Days 1 and 2 in culture. After Day 2, puromycin
was omitted and medium was changed every 3 d. Cell suspension from
one brain was seeded per well of a 12-well plate. Experiments were per-
formed when cells reached confluence, usually after 1 week in culture at
37°C and 5% CO2.
Treatment. Primary mouse cortical astrocytes were treated with 0.8 mM
DetaNONOate (Enzo Life Sciences) and 20 M of the phosphatidylinositol
3-kinase (PI3K) inhibitor LY294002 (2-[4-morpholinyl]-8-phenyl-1[4H]-
benzopyran-4-one hydrochloride), 25 M the mitogen-activated protein
kinase kinase (MEK) inhibitor PD98059 (2-[2-amino-3-methoxyphenyl]-
4H-1-benzopyran-4-one), 100nMof themTOR(mammalian targetof rapa-
mycin) blocker rapamycin, 20 M of the guanylate cyclase inhibitor ODQ
(1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one), 10 or 100M of nonselec-
tive inhibitor of cyclooxygenase (COX) indomethacin, or the selective
COX-2 inhibitor celecoxib for 30 min before DetaNONOate treatment
when indicated. Control experiments included the use of SulfoNONOate
(does not release NO), degraded DetaNONOate and the NO scavenger
CPTIO
[2-(4-carboxyphenyl)-4,4,5,5-tetramethyl-imidadazoline-1-oxyl-3-oxide].
Coculture experiments. For transwell coculture experiments, astrocytes
were seeded in 12 well inserts (BD; 0.4 m pore size) and cultured for
21 d. Inserts containing astrocytes were incubated for 12 h with 3 105
astrocytes, neurons, primary endothelial cells or bEnd.3 cells plated on 12
well plates (see Fig. 6C). During coculture 500 M L-arginine was added
to the corresponding medium as a substrate for nitric oxide synthase
(NOS). For inhibition studies bEnd.3 cells or endothelial cells were
preincubated for 30 min with 100 M of the NOS inhibitor L-NAME
(N-nitro-L-arginine methyl ester).
Fluorescence microscopy
Cells grown on Imaging Plates (zell-kontakt) were fixedwith 4% ice-cold
formaldehyde for 15min, permeabilizedwith 0.3%TritonX-100 (v/v) in
PBS and blocked for 1 h with 2% bovine serum albumin (BSA) (w/v) in
PBST (0.1%Tween 20 (v/v). Primary antibodies were diluted in blocking
buffer and incubated with cells for 1 h at room temperature. Subse-
quently, cells were washed and incubated with Alexa Fluor labeled sec-
ondary antibody in 2% BSA (w/v) in PBS for 1 h at room temperature.
Nuclei were stained with 2g/ml DAPI. Cells were washed with PBS and
microscopic analysis was performed immediatelywith the confocal laser-
scanning microscope TCS SP5 (Leica). The following antibodies were
used: rabbit anti-HIF-1 1:500 (Santa Cruz Biotechnology), mouse anti-
GFAP 1:1000 (Sigma), goat anti-rabbit Alexa 555 (Invitrogen) and goat
anti-mouse Alexa 488 1:2000 (Invitrogen).
Transfection and siRNA knockdown
For transfection, Lipofectamine 2000was used according tomanufactur-
er’s instructions. Transfection mixtures were prepared in a final volume
of 100l/well OptiMEMmedium containing 50 ng siRNA and 10g/ml
of Lipofectamine 2000. Cells were incubated for 5 h at 37°C and 5%CO2.
Subsequently, the transfection medium was replaced by complete me-
dium without antibiotics and cells were incubated for 20 h at 37°C and
5%CO2. For the siRNA silencing Stealth/ siRNAduplex oligonucleotides
specific for HIF-1 (5-CAAGCAGCAGGAAUUGGAACAUUAU-3)
and control siRNA (5-CAACGAGGAUAAGGUCAAUAGCUAU-3)
were purchased from Invitrogen.
Quantitative RT-PCR
For the quantification of mRNA, cells were washed with PBS, lysed and
total RNA was extracted using the 6100 nucleic prepstation (Applied
Biosystems) following the manufacturer’s protocol. Total RNA (9 l)
was used for cDNA synthesis with the Cloned AMV First Strand Synthe-
sis Kit (Invitrogen) according to the manufacturer’s specifications. qRT-
PCR was accomplished with Platinum SYBR Green qPCR Supermix
(Invitrogen) and 2 l cDNA in a volume of 25 l on the ABI Prism 7000
Sequence Detection System (Applied Biosystems). Expression values
were normalized to total RNA. For detection of specific cDNA, oligonu-
cleotide primers were used as indicated (Table 1).
Table 1. Sequences of primers used for RT-PCR of mouse RNA (orientation 5 to 3)
Primer Forward Reverse
HIF-1 CCCAAAGACAATAGCTTCGCA ACAGTCACCTGGTTGCTGCAA
GLUT1 ACCTCTTCCGAACCGACAGAT TCTGGAGCCATCAAAGTCCTG
GLUT2 TTCCGGAAGAAGAGTGGTTCG TGGTCGGTTCCTCGGTTTTAG
GLUT3 CACCTTCTTCAAAGTCCCGGA ATGCTGTTCAACTCCACACCG
HK1 CATTGTCTCCTGCATCTCCGA ATTCCGCAATCTAGGCTCGTC
HK2 CTTGCGAATATGGTTGCCTCA CCTCCCAATGCCTGATCTGAT
HK4 CATCCTGCTCAACTGGACCAA CATTGCCACCACATCCATCTC
PFKL AACGCTGCAATGGAGAGTTGT TCAAAGACGTAGGCAGCATCG
PFKFB3 TTCTCAGGTTTTTGCGGAGAAC GTGCACATGTATGAGCTGGCA
ALDOA GGCCATCATGGAAAATGCC TCAAGTCATGGTCCCCATCAG
PGK1 TTTGGACAAGCTGGACGTGAA GCTTGGAACAGCAGCCTTGAT
ENO1 AGATCCCTTTGACCAGGACGA AGCCTTGG CAATCCGCTTA
LDHA CAAAGTCCAAGATGGCAACCC AGCACCAACCCCAACAACTGT
LDHB ATTGCGTCCGTTGCAGATG TCCCAGAATGCTGATGGCA
PDK1 TTACGGATTGCCCATATCACG CCCGGTCACTCATCTTCACAGT
MCT1 TGTGACCCACGACATCCAAA TGAACACCCGGTAGGTTTTCC
MCT2 AAAACCCACGCACTTGCTCA GCCAAGGTCTGGAATGCAGAT
MCT4 GCCTGGTGGTCTTTTGCATCT TGGAGAACTTCTGAGTGCCCA
-actin ATGGAATCCTGTGGCATCCAT TCCTGCATCCTGTCAGCAATG
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Western blot analysis
Cells were washed with PBS, lysed in 8 M Urea buffer (8 M Urea, 9.5 M
Glycerin, 0.7 M SDS, 1 M DTT, 0.5 M Tris-HCl, pH 6.8, 22 mM Aprotinin,
2.2 mM Leupeptin, 1.46 mM Pepstatin), homogenized by centrifugation
through Qiashredder tubes (Qiagen) and denatured for 5 min at 95°C in
4 LDS Sample buffer (Invitrogen). Proteins were separated by 4–12%
BIS-Tris gels (Invitrogen) and transferred onto PVDF membrane (Mil-
lipore). To detect nonphosphorylated proteinsmembranes were blocked
for 30min with 5% skimmilk (w/v) in washing buffer (65mMNa2HPO4
* 2 H2O, 25 mM NaH2PO4 * H2O, 100 mM NaCl, 0.1% Tween (v/v),
pH7,5). For detection of phosphorylated proteins, a blocking buffer con-
taining 1% BSA (w/v), 10 mMNaF, 2 mMNa3VO4 and 5 mMNa4P2O7 in
TBST (10mMTris-HCl, pH 7.5, 150mMNaCl and 0.1%Tween 20 (v/v))
was used. Membranes were incubated overnight in presence of the pri-
mary antibody diluted in appropriate blocking buffer at 4°C. The following
antibodies were used: goat anti--actin 1:1000 (Santa Cruz Biotechnol-
ogy), rabbit anti-HIF-1 1:500 (Cayman Chemicals), rabbit anti-
phospho-p70S6 kinase (Thr389) 1:500 (Cell Signaling Technology),
rabbit anti-p70S6 kinase (Thr389) 1:1000 (Cell Signaling Technology),
rabbit anti-Akt 1:1000 (Cell Signaling Technology) 1:1000, rabbit anti-
phospho-Akt (Ser473) 1:1000 (Cell Signaling Technology). Afterward,
the membranes were washed 4 times for 10 min with washing buffer and
then incubated with either HRP-goat anti-rabbit IgG (DAKO) or HRP-
rabbit anti-goat IgG (DAKO) 1:2000 for 60 min at room temperature.
Blots were washed 4 times for 10 min with washing buffer and processed
using the SuperSignal West Femto Maximum Sensitivity substrate
(Pierce) in a 1:5 dilution. Chemiluminescence was detected and quanti-
fied using ImageJ software (NIH, Wayne Rasband, version 1.45e).
Measurement of NO
To determine total NO production in the supernatant of different cell
types nitrite and nitrate were measured using the Nitrate/Nitrite fluoro-
metric assay kit (Cayman Chemicals). Cells were seeded in equal cell
numbers and themedium of different the cell types was replaced by fresh
medium supplemented with 500 M L-arginine. Samples were collected
after 12 h of culture. The assay was performed as described by the man-
ufacturer using 50 l of medium. Fluorescence was measured with exci-
tation wavelength of 360 nm and emission wavelength of 430 nm.
Lactate assay
To measure lactate release in the supernatant of astrocytes the medium
was renewed and astrocytes treated as indicated. Sampleswere taken after
24 h. For lactate measurement after coculture astrocytes were cocultured
with the indicated cells for 12 h. After separation of astrocytes from
cocultured cells the medium was exchanged. Medium samples were
taken after 6 h.
Figure 1. NO increasesmRNA expression of selected glycolytic enzymes and glucose/lactate transporters in astrocytes.A, Primary cultures ofmurine cortical astrocyteswere treatedwith 0.8mM
DetaNONOate for the indicated time periods (3, 12, 24 h) comparedwith untreated controls (C).B, glycolytic pathway andDetaNONOate regulated transporter/enzymes as indicated by arrows. Each
data point represents the mean SEM of triplicate samples from one experiment. The experiment was repeated three times on different cell preparations with similar results. Glc, glucose; G6P,
glucose 6-phosphate; F6P, fructose 6-phosphate; F1,6BP, fructose 1,6-bisphosphate; F2,6BP, fructose 2,6-bisphosphate; GADP, glyceraldehyde 3-phosphate; 1,3-BPG, 1,3-bisphosphoglycerate;
3PG, 3-phosphoglycerate; 2PG, 2-phosphoglycerate; PEP, phosphoenolpyruvate; Pyr, pyruvate; AcCoA, acetyl-CoA; Lac, lactate.
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Medium (100 l) was incubated for 5 min with 500 l 0.3 M HClO4 to
precipitate proteins from samples. After 5 min of centrifugation (13,000
rpm) 450 l of clear supernatant were neutralized with 100 l saturated
KHCO3 solution on ice. Samples were centrifuged (13,000 rpm) and 150l
of supernatant were incubated with 650 l test buffer (250 nmol/L Tris-
glutamate pH 8.75, 3.6 nmol/L NAD) and 15 l enzyme solution (400
U/ml lactate dehydrogenase (LDH) (Roche), 24 U/ml glutamate-pyruvate-
transaminase (GPT) (Roche) in 0.1 M Tris buffer) for 30 min at room tem-
perature. Absorbance was measured at 340 nm. Lactate release was
normalized to protein content/well, which was measured by the method of
Lowry et al. (1951).
Statistics
All data are presented asmean SD. All experiments were repeated at least
three times. Statistical comparison between groups was done using the Stu-
dent’s t test or appropriate ANOVA followed by Bonferroni post-test.
Results
NO selectively enhances mRNA expression of glycolytic
enzymes and glucose/lactate transporters in astrocytes
Application of the NO donor DetaNONOate (0.8 mM) on primary
cultures of mouse cortical astrocytes led to a time-dependent in-
crease in mRNA levels of genes coding for a variety of glycolysis-
associated enzymes that include hexokinase-1 (HK1), hexokinase-2
(HK2), phosphofructokinase kinase L (PFKL), 6-phosphofructo-2-
kinase/fructose-2,6-biphosphatase 3 (PFKFB3), aldolase A
(ALDOA),phosphoglycerate kinase 1 (PGK1), enolase (ENO1), lac-
tate dehydrogenase A (LDHA), and pyruvate dehydrogenase kinase
1 (PDK1) (Fig. 1A). Moreover, DetaNONOate enhanced the
mRNA expression of glycolysis-related transporters such as
the glucose transporter-1 (GLUT1) and the monocarboxylate
transporter-4 (MCT4) (Fig. 1A) implyingnot only an increased glu-
cose uptake into astrocytes but also enhanced glycolysis, lactate pro-
duction and release (Fig. 1B). In contrast, DetaNONOate did not
enhance the mRNA expression of other genes like hexokinase-2
(HK2), lactate dehydrogenase B (LDHB), and themonocarboxylate
transporters MCT1 andMCT2 (Fig. 1A).
NOmodulates glycolytic gene expression in astrocyte via
HIF-1 stabilization
HIF-1 is a transcriptional regulator of hypoxia-induced glycol-
ysis that is constitutively destabilized under normoxic conditions
(Semenza et al., 1994). However, it has been shown that HIF-1
can be stabilized byNO innormoxia (Kasuno et al., 2004). There-
fore, the putative involvement of HIF-1 in NO-regulated gene
expression was investigated in cultures of astrocytes. Application
of DetaNONOate on astrocytes led to a time- and concentration-
dependent HIF-1 stabilization (Figs. 2A,B). HIF-1 protein
was most efficiently stabilized after 6–12 h of DetaNONOate
treatment. HIF-1was already detected at a concentration of 0.4
mM DetaNONOate with a maximal effect between 0.8 and 1.2
mM. In contrast to the effect observed in astrocytes, NO-induced
Figure 2. NO stabilizes HIF-1 protein in astrocytes. A–C, HIF-1 protein levels were obtained byWestern blot analysis of primary astrocytes treated with 0.8 mM DetaNONOate (DETA) for the
indicated time periods (A), increasing concentrations of DetaNONOate for 12 h (B), or with 0.8 mM DetaNONOate for 12 h in comparison with DetaNONOate-treated primary cortical neurons (C).
-actin served as loading control.D, Immunocytochemical staining of HIF-1 in primary cultures of mouse cortical astrocytes treatedwith 0.8mM DetaNONOate for 12 h comparedwith untreated
controls (Ctr).
Figure 3. Inhibition of DETANONOate-inducedHIF-1 stabilization andMCT4mRNA expression
by CPTIO. Primary astrocytes were pretreated for 30 min with 100 or 250M of the NO scavenger
CPTIO orwithout scavenger before application of 0.8mMDetaNONOate (DETA) for 12 h andWestern
blotanalyses forHIF-1and-actin (A)aswellasqRT-PCRforMCT4expression(B)wereperformed.
Control experiments included the treatmentwithSulfoNONOate (SULFO)andDetaNONOate thatwas
degraded for 72 h in B. A representative Western blot for HIF- and-actin is shown from three
independent experiments. MCT4mRNA levels are shown as mean SEM of triplicate samples, re-
peated three times ondifferent cell preparationswith similar results.
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HIF-1 protein stabilization could not be detected in mouse pri-
mary cultures of cortical neurons (Fig. 2C). HIF-1 translocates
to the nucleus after activation, where it regulates the transcrip-
tion of various genes. Using immunocytochemistry HIF-1 was
foundnotonly to stabilizebutalso tobe locatedwithin thenucleusof
DetaNONOate-treated astrocytes (Fig. 2D). TheNO scavenger CP-
TIO, at 250M, largely reduced the amount of HIF-1 protein sta-
bilized by 12 h of DetaNONOate treatment (Fig. 3A) and abolished
the induction of MCT4 mRNA (Fig. 3B). No effects on MCT4
mRNA expression were observed after 12 h of treatment with Sul-
foNONOate or degraded DetaNONOate (Fig. 3B).
To analyze the dependency of NO-induced glycolytic enzyme
and glucose/lactate transporter expression on HIF-1, HIF-1
was knocked down in cultured astrocytes
using a HIF-1-specific siRNA. HIF-1
mRNA levels were reduced by 90%using a
specific HIF-1 siRNA compared with the
application of an unspecific control siRNA
(Fig. 4A). Treatment with HIF-1-specific
siRNA prevented the effect of DetaNONO-
ate onHIF-1protein stabilizationwhile an
unspecific control siRNA had no effect on
NO-induced HIF-1 protein stabilization
(Fig. 4B). Transfection of cultured astro-
cyteswith theHIF-1-specific siRNAbefore
exposure with DetaNONOate greatly
reduced or abolished the NO-induced
increase of mRNA levels for the glycolytic
enzymes HK2, PFKL, PFKFB3, PDK1,
ALDOA, PGK1, ENO1, and LDHA as well
as the glucose/lactate transporters GLUT1,
GLUT3, and MCT4 (Fig. 4C). The expres-
sion levels of other genes like HK1 (Fig. 4C)
and -actin (data not shown) were not af-
fected by HIF-1 siRNA with or without
NO treatment.
NO-dependent HIF-1 stabilization
and transcriptional activation of
glycolytic genes in astrocytes require
the PI3K/Akt signaling pathway and
COX activity, but not soluble guanylate
cyclase signaling
Soluble guanylate cyclase (sGC) produces
intracellular cGMP and is a main target of
NO in many cell types. Therefore, to test
the implication of this signaling cascade,
astrocytes were treated with 100M of the
sGC inhibitor ODQ before stimulation
with DetaNONOate. ODQ was unable
to neither prevent NO-induced HIF-1
stabilization (Fig. 5A) nor target gene ex-
pression, as exemplified by MCT4 gene
expression (Fig. 5B). Concomitantly, the
cGMP analog 8-Bromo-cGMP had no ef-
fect onMCT4mRNA levels (Fig. 5B). De-
taNONOate increased phosphorylation
of Akt and the downstream transcrip-
tional activator pS6K in astrocytes, an
effect that was reduced by the PI3K inhib-
itor LY294002 as well as the mTOR inhib-
itor rapamycin (data not shown). Indeed,
pretreatment of astrocytes with LY294002
and rapamycin, but also with the MEK-inhibitor PD98059 re-
ducedNO-inducedHIF-1 protein stabilization significantly in-
dicating the involvement of this pathway. (Fig. 5C). In
parallel, NO-induced MCT4 gene expression reflecting glyco-
lytic genes sensitive to NO, was reduced in astrocytes pretreated
with each of these inhibitors (Fig. 5D).
Prostaglandin E2 (PGE2) released by astrocytes plays a pivotal
role in arteriole relaxation at the neurovascular unit (Zonta et al.,
2003a, 2003b). As PGE2was shown to induceHIF-1 andCOX-2
inhibitors attenuated the PI3K/Akt-mediated effect of IL-1 on
HIF-1 induction (Jung et al., 2003), we tested whether COX
activation is involved in NO-dependent HIF-1 stabilization.
In fact, NO-induced HIF-1 protein stabilization was reduced
Figure 4. HIF-1 siRNA knockdown prevents NO-induced gene expression. A, B, Primary astrocytes were transfected with
HIF-1-specific siRNA or unspecific scrambled siRNA (Scr) 24 h before DetaNONOate treatment and HIF-1 knockdown was
confirmed by qRT-PCR (A) and Western blot analysis (B). C, mRNA expression levels of glycolytic enzymes and glucose/lactate
transporters were obtained by qRT-PCR 12 h after application of 0.8 mM DetaNONOate (DETA) and compared with untreated
controls (C). Each data point represents themean SEMof triplicate samples fromone experiment. The experimentwas repeated
three times on different cell preparations with similar results.
Brix et al. • NO Enhances Glycolysis via HIF-1 in Astrocytes J. Neurosci., July 11, 2012 • 32(28):9727–9735 • 9731
or abolished when astrocytes were pre-
treated with 100 M of the nonselective
COX inhibitor indomethacin or the se-
lective COX-2 inhibitor celecoxib, re-
spectively (Fig. 5E) and this effect was
paralleled by largely reduced MCT4
mRNA expression (Fig. 5F ).
Endothelial cells promote HIF-1
stabilization and glycolytic gene
expression in astrocytes via
NO production
To identify the possible source of cell-
derived NO, the production of NO by dif-
ferent brain cells in culture was evaluated
by measuring the accumulation in their
supernatant of two stableNOmetabolites,
nitrite and nitrate. bEnd.3 cells (a cell line
derived from endothelial cells) and, to a
larger extent, primary cultures of mouse
endothelial cells derived from brain capil-
laries constitutively produced significant
amounts of NO while primary cultures of
mouse cortical astrocytes or neurons as well
as CHO cells that served as negative control
did not produce significant amounts of NO
products (Fig. 6A). Treatment of bEnd.3
cells or endothelial cells with 100 M of the
NOS inhibitor L-NAME reduced their NO
production (Fig. 6B).
The capacity of these different cell
types to cause HIF-1 stabilization and
enhance glycolytic gene expression in
astrocytes was investigated in a cocul-
ture system. Primary cultures of cortical
astrocytes were seeded in transwell in-
serts and cocultured cells were seeded on the bottom of the
corresponding culture plates (Fig. 6C). Coculture of primary
cultures of endothelial cells with astrocytes for 12 h led to
HIF-1 stabilization in astrocytes (Fig. 6D). Furthermore, co-
culture with endothelial cells enhanced the expression of
GLUT1 and MCT4 as well as glycolytic enzymes HK2 and
PGK1 in astrocytes (Fig. 6E). These effects were abolished by
pretreatment with L-NAME before coculture (Fig. 6D,E). No
such effect was observed in astrocytes cocultured with neu-
rons. Similar results were obtained when bEnd.3 cells were
used for cocultures instead of primary cultures of endothelial
cells (data not shown). In contrast to the mRNA levels of
GLUT1/MCT4 and glycolytic enzymes, mRNA levels of MCT1
and -actin in astrocytes were not changed by coculture with
endothelial cells (Fig. 6E).
Endothelial cells induce lactate release from astrocytes via
NO signaling
To evaluate the functional consequence of enhanced expres-
sion of glycolytic enzymes and glucose/lactate transporters,
the effect of DetaNONOate on lactate production was mea-
sured in cultured astrocytes. After 24 h of treatment with De-
taNONOate, a significant increase in lactate accumulation was
observed (Fig. 7A). Transfection with HIF-1-specific siRNA
prevented the NO-induced increase in lactate (Fig. 7A). Fi-
nally, coculture of astrocytes with endothelial cells led to an
increased lactate release in astrocytes compared with astro-
cytes cocultured with astrocytes or neurons (Fig. 7B). This
effect was abolished by L-NAME.
Discussion
It has been well documented that astrocytes and neurons have a
differentmetabolicprofile, bothat rest anduponactivation (Pellerin
et al., 2007; Pellerin andMagistretti, 2011). At rest, astrocytes have a
higher glycolytic activity than neurons, an observationwhich is sup-
ported by results obtained with transcriptomic analysis on acutely
isolated cells indicating apredominant expressionof genes encoding
glycolytic enzymes in astrocytes versusneurons (Rossner et al., 2006;
Lovatt et al., 2007; Cahoy et al., 2008). In addition, recent results in
vivo also suggest that astrocytes, in contrast to neurons, respond to
neuronal activationby exhibiting apredominant glycolytic response
(Chuquet et al., 2010). Whether such a distinctive feature depends
only on a constitutive difference in expression of genes encoding
glycolytic enzymes or whether it can be further reinforced by exter-
nal signals was so far unknown. Our results provide support for the
second possibility. Indeed, a selected group of genes encoding either
glycolytic enzymesor transporters forglucoseand lactatewere found
tobeupregulated in cultured astrocytes byNO. In aprevious report,
NO was shown to induce the expression of the monocarboxylate
transporter MCT4 in cultured astrocytes (Marcillac et al., 2011).
The present data not only confirm this observation but further
extend it to include this time a selective group of proteins belong-
ing to the same pathway and identifies HIF-1 as the responsible
transcription factor. Thus, it appears that the basal metabolic
Figure 5. PI3K/Akt/mTor andMAPK kinase but not soluble guanylate cyclase pathways are involved in NO-mediated HIF-1 stabili-
zation. A, B, Primary astrocytes were pretreated for 30 min with 100M selective guanylate cyclase inhibitor ODQ or without inhibitor
before application of 0.8 mM DetaNONOate (DETA) or 8-Bromo-cGMP (8-Br-cGMP) for 12 h and Western blot analyses for HIF-1 and
-actin as loading control (A) as well as qRT-PCR for MCT4 expression (B) was performed. C, D, The effect of kinase inhibitors on
DetaNONOate-dependent HIF-1 protein stabilization (C) and MCT4 mRNA expression (D) was analyzed in astrocytes pretreated with
LY294002 (L), Rapamycin (R), PD98059 (P), or without inhibitor 30 min before addition of 0.8 mM DetaNONOate. E, F, The effect of COX
inhibitors on DetaNONOate-dependent HIF-1 protein stabilization (E) andMCT4mRNA expression (F ) was analyzed in astrocytes pre-
treatedwith indomethacin (I) or celecoxib (C), orwithout inhibitor 30min before addition of 0.8mMDetaNONOate. Shown are represen-
tative Western blots for HIF- and -actin. HIF-1 was normalized to -actin and quantification was performed on two to three
independentexperimentsshownasmeanSEM(*p0.05,**p0.01,and***p0.001comparedwithDetaNONOatealone).MCT4
mRNA levels are shownasmean SEMof triplicate samples, repeated three times ondifferent cell preparationswith similar results.
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profile of astrocytes can be reinforced by an exogenous signal
such as NO.
The transcription factorHIF-1 is a heterodimeric complex com-
prising the subunitsHIF-1 andHIF-1 (Wang et al., 1995). HIF-1
controls transcription of genes involved in crucial aspects of cellular
function like glucose and iron metabolism, energy homeostasis or
vascularization.Atphysiologicaloxygenconcentrations, twoproline
residues of HIF-1 (Pro-402 and Pro-564) are hydroxylated by
prolyl hydroxylases (PHDs) (Schofield and Zhang, 1999). As a con-
sequence, von-Hippel-Lindau protein binds to HIF-1 and
ubiquitin-dependentproteasomaldegradation is triggered (Kamura
et al., 2000).Under hypoxic conditions PHDs are inactivated,which
leads to HIF-1 stabilization. Upon stabilization, HIF-1 translo-
cates to the nucleus where it dimerizes with HIF-1 and binds to
hypoxia response elements (HRE) contained in the promoter of
target genes such as enzymes and transporters involved in glycolysis
(Semenza, 1999). In addition to hypoxia, some chemical com-
pounds like deferoxamine and carbon monoxide have been de-
scribed to stabilize HIF-1 under normoxic conditions (Wang and
Semenza, 1993; Kasuno et al., 2004; Choi et al., 2010). NO has been
shown also before to have an impact onHIF-1 stabilization under
Figure 7. NO and coculture with endothelial cells stimulate lactate release from astrocytes.
A, Primary astrocyteswere transfectedwith Hif-1 siRNA or scrambled (Src) control siRNA 24 h
before the application of 0.8 mM DetaNONOate (DETA). After 24 hmedium samples were taken
and lactate was measured. B, Primary astrocytes were cocultured for 12 h with primary endo-
thelial cells (endo), primary astrocytes (astro), or primary neurons (neuro) and lactate was
measured in fresh medium after 6 h of incubation of separated astrocytes. (n 6, ***p
0.001 compared with untreated controls (C) or L-NAME-treated cells. Results were from two
independent experiments.
Figure 6. HIF-1 and HIF-1 target gene expression is induced in astrocytes by coculture with endothelial cells. A, B, NO production in bEnd.3 cells, primary endothelial cells (endo), primary
astrocytes (astro), primary neurons (neuro), and CHO cells after culturing for 12 h (A) and after additional treatment of bEnd.3 cells and primary endothelial cellswith 100M L-NAME (B) as analyzed
by nitrite/nitrate measurement. C–E, HIF-1 (D) and HIF-1 target gene mRNA levels (E) were analyzed in lysates from astrocytes (inset) cocultured for 12 h with indicated cells as shown in C by
Western blot analysis or qRT-PCR. Primary endothelial cells were also pretreated with 100M L-NAME before coculture. Each data point represents means SEM from two to three independent
experiments. MCT4 mRNA levels are shown as mean SEM of triplicate samples, repeated three times on different cell preparations with similar results.
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normoxic conditions (Sandau et al., 2001; Kasuno et al., 2004; Park
et al., 2008)anddestabilizationunderhypoxicconditions (Sogawaet
al., 1998). Here, we detected HIF-1 stabilization under normoxic
conditions in NO-treated astrocytes, but not in neurons. This is in
accordancewith earlier findings showing thatNO induces glycolysis
in astrocytes but not in neurons (Almeida et al., 2001). In primary
astrocytes, theNO-inducedenhancementofglycolysiswasmediated
by HIF-1 via the PI3K/AKT/mTOR pathway but independent of
soluble guanylate cyclase as also shown in other cell types before
(Sandau et al., 2000, 2001).Most interestingly, induction ofHIF-1
via the PI3K/AKT/mTOR pathway had been shown previously to
involveCOX-2activation ina lungcancer cell line (Junget al., 2003).
The NO-dependent stabilization of HIF-1 observed in the present
study was also abolished by the COX-2 inhibitor celecoxib suggest-
ing the involvement of prostaglandins which are also central astro-
cytic mediators of neurovascular coupling at the gliovascular unit
(Zonta et al., 2003a, 2003b). However, the detailed mechanistic in-
teractions between NO, the PI3K/AKT/mTOR pathway and COX
activation for the regulation of HIF-1 stabilization in astrocytes
remain to be clarified in future studies.
Our findings imply a specific regulation of glycolysis in astro-
cytes, as opposed to neurons,mediated at least in part byHIF-1. In
fact, it is notonlyNO-inducedgeneexpressionof glycolytic enzymes
that isdependentonHIF-1, but also lactateproductionandrelease.
Interestingly, it was previously shown thatNOenhances lactate pro-
duction and release by astrocytes, but the mechanism invoked in-
volved inhibition of respiration and activation of the glycolytic
enzyme phosphofructokinase (Almeida et al., 2004). These two
mechanisms are notmutually exclusive but probably represent tem-
porally distinct levels of regulation. For example, respiration can be
acutely reduced by NO via its inhibition of cytochrome c oxidase
(Bolan˜os et al., 1994). In parallel, the activity of pyruvate dehydro-
genase (and thus of the TCA cycle as well as of oxidative phosphor-
ylation) is regulatedby the enzymepyruvate dehydrogenase kinase 1
(PDK1). NO treatment enhanced PDK1 expression in astrocytes
(andnot in neurons), providing anothermean to reduce respiration
while favoring glycolysis. In this regard, NO could represent a signal
exerting either transient or long-lasting modifications in metabolic
activity, depending of the requirements of neighboring cells and the
type of activation.
In the CNS, NO is produced by three NO synthases that are
expressed in neurons (nNOS), astrocytes (iNOS) and endothelial
cells (eNOS) (Bredt et al., 1990; Fo¨rstermann et al., 1991). Taking
into account the tight spatial structure in neurovascular units, we
hypothesized that NO from one of those cell types could be a suffi-
cient factor to stabilize HIF-1 in astrocytes, setting astrocytes in an
enhanced glycolytic status. Endothelial cell-producedNO takes part
inmodulation of leukocyte-endothelial interaction, smoothmuscle
cell proliferation and regulation of the local vascular tone, i.e., vaso-
dilation (Atochin andHuang, 2010). In the brain, 99% of the capil-
laries are enwrapped tightly by astrocytic end-feet and intense
interactions have been shown in this gliovascular unit (Abbott et al.,
2006). Inour studieswe coulddemonstrate that primary endothelial
cells constitutively produce more NO then astrocytes or neurons.
We could demonstrate that coculture of astrocytes with endothelial
cells stabilizes HIF-1 in astrocytes and induces MCT4 mRNA ex-
pression. On the contrary, coculture with cortical neurons or astro-
cytes had no such effect, suggesting that endothelial cells represent
themain sourceofNO.However,wecannot exclude thatneuronsor
astrocyteswith higher nNOS/iNOS activity or stimulated cells could
also produce NO in amounts sufficient to stabilize HIF-1 in sur-
rounding astrocytes.
It is well established that NO produced by endothelial cells in-
duces vasodilatation of local capillaries allowing a certain local glu-
cose flux. Based on our findings, we propose an extended model of
the neurovascular unit that includes glucose metabolism and pro-
vides a molecular mechanism explaining production and release of
lactate in astrocytes (Fig. 8). In this model, endothelial cell-derived
NO, via its stabilization of HIF-1 and subsequent increase in ex-
pression of glycolytic enzymes and glucose/lactate transporter in
nearbyastrocytes, leads to enhancedglial glucoseuptakeviaGLUT1,
enhanced glycolysis and lactate production as well as release via
MCT4. A fast lactate release from astrocytes to activated neurons, as
waspreviouslydemonstrated tobe triggeredbothbyglutamate (Pel-
lerin andMagistretti, 1994) and K (Bittner et al., 2011), should be
facilitated if astrocytes are already inapreferredglycolytic status.The
Figure 8. Model of stimulated lactate production in astrocytes by nitric oxide (NO) released from endothelial cells. NO stabilizes HIF-1 in astrocytes leading to an increased expression of key
glycolytic enzymes and glucose/lactate transporters. Glucose uptake fromarterial supply is increased in astrocytes via GLUT1, lactate production is increased through enhanced glycolysis and export
of lactate from astrocytes involves MCT4.
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gliovascular unit would be able, by these mechanisms, to satisfy en-
ergy needs of most brain cell types.
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